Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD

por Lewis, S J, Rodbard, H W, Fox, K M, Grandy, S
Publicado 2008

Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co‐formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomiz...

por Rodbard, H. W., Cariou, B., Pieber, T. R., Endahl, L. A., Zacho, J., Cooper, J. G.
Publicado 2016

Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin

por Rodbard, H. W., Seufert, J., Aggarwal, N., Cao, A., Fung, A., Pfeifer, M., Alba, M.
Publicado 2016

Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes

por Rodbard, H W, Cariou, B, Zinman, B, Handelsman, Y, Wolden, M L, Rana, A, Mathieu, C
Publicado 2014

Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin‐naïve people with Type 2 diabetes: the DUAL...

por Rodbard, H. W., Bode, B. W., Harris, S. B., Rose, L., Lehmann, L., Jarlov, H., Thurman, J.
Publicado 2016

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes

por Rodbard, H. W., Buse, J. B., Woo, V., Vilsbøll, T., Langbakke, I. H., Kvist, K., Gough, S. C. L.
Publicado 2016

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

por Rodbard, H W, Cariou, B, Zinman, B, Handelsman, Y, Philis-Tsimikas, A, Skjøth, T V, Rana, A, Mathieu, C
Publicado 2013

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled tr...

por Ahmann, A., Rodbard, H. W., Rosenstock, J., Lahtela, J. T., de Loredo, L., Tornøe, K., Boopalan, A., Nauck, M. A.
Publicado 2015

One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial...

por Gough, S. C. L., Bode, B. W., Woo, V. C., Rodbard, H. W., Linjawi, S., Zacho, M., Reiter, P. D., Buse, J. B.
Publicado 2015

Is adiposopathy (sick fat) an endocrine disease?

por Bays, H E, González-Campoy, J M, Henry, R R, Bergman, D A, Kitabchi, A E, Schorr, A B, Rodbard, H W
Publicado 2008